GSK1120212 in Surgically Resectable Oral Cavity Squamous Cell Cancer

NCT01553851 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Neoplasms, Oral
Mouth Neoplasms

Interventions

DRUG: GSK1120212

Sponsor

Washington University School of Medicine

Collaborators

[object Object]